Skip to main content

Verastem Oncology, INC

Needham, MA
United States

TAP Partner

Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Verastem entered into a definitive agreement to sell its global commercial and development rights to duvelisib to Secura Bio, Inc., an integrated biopharmaceutical company dedicated to the worldwide commercialization of significant oncology therapies. Secura Bio continues to develop duvelisib in PTCL as enrollment of the Phase 2 registration-directed PRIMO study recently was completed.

Program Name(s)
Therapy Acceleration Program
Verastem